124 related articles for article (PubMed ID: 37579537)
21. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
Bondi MW; Salmon DP; Galasko D; Thomas RG; Thal LJ
Psychol Aging; 1999 Jun; 14(2):295-303. PubMed ID: 10403716
[TBL] [Abstract][Full Text] [Related]
22. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease.
Xing F; Meng T; Therriault J; Luo J; Zhang H;
J Integr Neurosci; 2021 Jun; 20(2):277-286. PubMed ID: 34258926
[TBL] [Abstract][Full Text] [Related]
24. Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
Supasitthumrong T; Tunvirachaisakul C; Aniwattanapong D; Tangwongchai S; Chuchuen P; Tawankanjanachot I; Snabboon T; Hemrungrojn S; Carvalho AF; Maes M
J Alzheimers Dis; 2019; 71(3):797-811. PubMed ID: 31424390
[TBL] [Abstract][Full Text] [Related]
25. Brain myelin water fraction is associated with APOE4 allele status in patients with cognitive impairment.
Park M; Lee HP; Kim J; Kim DH; Moon Y; Moon WJ
J Neuroimaging; 2022 May; 32(3):521-529. PubMed ID: 34964524
[TBL] [Abstract][Full Text] [Related]
26. Education, APOE ε4, and Cognition in Individuals with Subjective Cognitive Decline with Worry in the SILCODE Study.
Chen G; Lin L; Yang K; Han Y
Curr Alzheimer Res; 2021; 18(6):492-498. PubMed ID: 34598665
[TBL] [Abstract][Full Text] [Related]
27. Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
Caillaud M; Maltezos S; Hudon C; Mellah S; ; Belleville S
J Alzheimers Dis; 2023; 94(3):1047-1056. PubMed ID: 37355896
[TBL] [Abstract][Full Text] [Related]
28. The association of apolipoprotein E (ApoE) genotype and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis.
Naseri A; Baghernezhad K; Seyedi-Sahebari S; Alhoseini SA; Gholipour-Khalili E; Zafarani F; Talebi M
Mult Scler Relat Disord; 2022 Sep; 65():104011. PubMed ID: 35803087
[TBL] [Abstract][Full Text] [Related]
29. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
30. APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review.
Emrani S; Arain HA; DeMarshall C; Nuriel T
Alzheimers Res Ther; 2020 Nov; 12(1):141. PubMed ID: 33148345
[TBL] [Abstract][Full Text] [Related]
31.
Sun J; Zhu Z; Chen K; Wei D; Li X; Li H; Zhang J; Chen X; Chen Y; Zhang Z
Aging (Albany NY); 2020 Jun; 12(12):12019-12031. PubMed ID: 32572010
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E and cognitive performance: a meta-analysis.
Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
[TBL] [Abstract][Full Text] [Related]
33. Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals.
Olofsson JK; Larsson M; Roa C; Wilson DA; Jonsson Laukka E
Behav Genet; 2020 Jan; 50(1):3-13. PubMed ID: 31760549
[TBL] [Abstract][Full Text] [Related]
34. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.
Mayeux R; Small SA; Tang M; Tycko B; Stern Y
Neurobiol Aging; 2001; 22(4):683-9. PubMed ID: 11445269
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review.
El Haj M; Antoine P; Amouyel P; Lambert JC; Pasquier F; Kapogiannis D
Ageing Res Rev; 2016 May; 27():15-22. PubMed ID: 26876367
[TBL] [Abstract][Full Text] [Related]
36. Frailty effects on non-demented cognitive trajectories are moderated by sex and Alzheimer's genetic risk.
Thibeau S; McDermott K; McFall GP; Rockwood K; Dixon RA
Alzheimers Res Ther; 2019 Jun; 11(1):55. PubMed ID: 31221191
[TBL] [Abstract][Full Text] [Related]
37. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
[TBL] [Abstract][Full Text] [Related]
38. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
39. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network.
Bussy A; Snider BJ; Coble D; Xiong C; Fagan AM; Cruchaga C; Benzinger TLS; Gordon BA; Hassenstab J; Bateman RJ; Morris JC;
Neurobiol Aging; 2019 Mar; 75():42-50. PubMed ID: 30530186
[TBL] [Abstract][Full Text] [Related]
40. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
